课题基金 / 基金详情

Effects of extracellular matrix on changes of phenotype and gene expression in vascular smooth muscle cells

Effects of extracellular matrix on changes of phenotype and gene expression in vascular smooth muscle cells
细胞外基质对血管平滑肌细胞表型及基因表达变化的影响
批准号:
04670371
负责人:
MURANO Shunichi
金额:
$1.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

MURANO Shunichi的其他基金

相关文献

中文摘要
翻译
我们观察了内皮剥脱对血管平滑肌细胞(SMC)表型变化的影响。剥脱后2天或5天的主动脉外植体的SMC生长速度明显高于未经处理的SMC。剥脱5d后,主动脉SMC也可观察到乙酰化低密度脂蛋白的清除途径和生长刺激因子(S)的自分泌,而未经处理的SMC则未见此现象。这些获得性病理特征与动脉粥样硬化病变的内膜SMC相似。这些结果表明,表型改变的临界点是在治疗后很早的时间,它发生在新生内膜形成之前的主动脉中层。另有实验表明,糖尿病兔主动脉SMC表达PDGF-β,对PDGF-AB、PDGF-BB或全血清液反应迅速。其他实验表明,肿瘤坏死因子-α刺激SMC由收缩表型向合成型转化。提示中膜SMC对动脉内膜损伤的早期反应对调控动脉粥样硬化形成的后续步骤具有重要意义。我们现在正在进行实验,以阐明内皮剥脱后表型改变的初始阶段基因表达的变化。之后,将进一步阐明SMC与细胞外基质的相互作用对SMC表型的影响,以评估调控SMC表型变化早期步骤的可能性。
英文摘要
We have examined effects of endothelial denudatio of phenotype cange of vasclar smooth muscle cells(SMC). Outgrowth rate of SMC from explants of aorta 2 or 5 days after denudation was much higher than that from untreated aorta. Scavenger pathway for acetylated low density lipoprotein and autocrine secretion of growth stimulator(s) were also observed inSMC from the aorta 5 days after denudation but not in SMC from untreated aorta. These acquired pathological ahcracters were similar to those of intimal SMC from atherosclerotic lesions. These results suggest that critical point of the phenotype change is at very early time after the treatment and it occurs within the aortic media before formation of neo-intima. another experimants revealed that SMCfrom aorta of diabetic rabbits expressed PDGF beta and the SMC showed rapid growthrate responded to PDGF-AB, PDGF-BB or whole serum. The other experiments showed that tumor necrosis factor-alpha stimulated SMC to change their phenotype from contractile to synthetic type. These data suggest that early response of medial SMC to intimal injury must ve very important to regulate the following steps to formation of atherosclerosis. We are now engaging in experiments to clarify changes of gene expression in the initial step of phenotype change after endothelial denudation. After that, effects of interaction between SMC and extracellular matrix on the phenotype of SMC will be further elucidated to assess possibilities to regulate the early step of phenotype change.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
Tetsuto Kanzaki et al: "Increased plasma fibronectin in Werner syndrome" The Lancet. 339. 1244 (1992)
Tetsuto Kanzaki 等人:“维尔纳综合征中血浆纤连蛋白增加”《柳叶刀》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Seijiro Mori et al: "Decreased expression of the platelet-derived growth fuctor β-receptor in fibroblasts from a patient with Werner's syndrome" Eur J Clin Invest. 23. 161-165 (1993)
Seijiro Mori 等人:“维尔纳综合征患者成纤维细胞中血小板衍生生长因子 β 受体的表达降低”Eur J Clin Invest 23. 161-165 (1993)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
村野俊一他: "リスクファクターの新しい見方ー老化と動脈硬化「動脈硬化症update」(高久史磨監修)" 中外医学, 199 (1992)
Shunichi Murano 等人:“风险因素的新视角 - 衰老和动脉硬化‘动脉硬化更新’(由 Fumima Takahisa 监督)”Chugai Medical,199 (1992)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nobuhiro Morisaki et al: "vitamin E and atherosclerosi : From the view point of arterial wall cell function, In "Vitamin E"" Japan Scientific Societies Prss (Tokyo) and Karger (Basel). 368 (1993)
Nobuhiro Morisaki 等人:“维生素 E 和动脉粥样硬化:从动脉壁细胞功能的角度来看,在“维生素 E”中”日本科学学会 Prss(东京)和 Karger(巴塞尔)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 28 条
    Research on abnormal mitochondria and its change in gene expression in cellular senescence.
    Effects of abnormal gene expression on accelerated atherosclerosis in Werner syndrome.
    • 批准号:
      07670515
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1995
    • 负责人:
      MURANO Shunichi
    • 依托单位:
    Gene therapy of atherosclerosis by regulation of actin binding protein gene.
    • 批准号:
      07557230
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $1.66万
    • 财政年份:
      1995
    • 负责人:
      MURANO Shunichi
    • 依托单位: